article thumbnail

Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says

Fierce Pharma

Bayer recently laid out its ambition | Bayer recently laid out its ambition to achieve $10 billion in sales from its oncology business by 2030 and become a top 10 cancer drug player. To get there, the company is looking outside for a “midsize acquisition,” Bayer’s oncology chief Christine Roth said.

article thumbnail

Sales Goals That Will Actually Achieve This Year’s Sales Objectives

Integrity Solutions

Sales goals are always on our minds when a new year kicks off or when a salesperson starts a new position, but it’s not uncommon to see that attention and energy fizzle out as the weeks and months go by. Sales goals are more than a single conversation or a quota number. Effective Goal-Setting for Salespeople.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why Salespeople Fail to Reach Their Sales Goals

Integrity Solutions

Our research has shown that there are five factors that affect whether or not someone achieves their sales goals. As you coach and develop your sales team on reaching their sales goals, have them really think about and then answer the following four questions. New Year’s resolutions.

article thumbnail

What Stands Between Salespeople and Achieving Their Sales Goals?

Integrity Solutions

How would your salespeople grade themselves when it comes to the key dimensions of sales success? Namely, their ability to clearly set (and hit) their sales goals. What Stands Between Salespeople and Achieving Their Sales Goals ? But reaching goals isn’t just a matter of knowing how.

article thumbnail

In boost to GSK's £3B plan for Blenrep, myeloma ADC shows survival edge over J&J's Darzalex

Fierce Pharma

GSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks to a key patient survival win. GSK’s £3 billion sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks to a key head-to-head patient survival win against J&J’s Darzalex

article thumbnail

With capacity upgrades ready to roll, Sanofi stands firm on blockbuster sales goal for RSV drug in 2024

Fierce Pharma

While manufacturing and supply hitches have troubled the rollout of Sanofi’s key respiratory syncytial virus (RSV) drug, the near-term expected approval of a pair of new filling lines is giving the | While manufacturing and supply hitches have troubled the rollout of Sanofi’s key respiratory syncytial virus drug, the near-term expected approval of (..)

article thumbnail

AstraZeneca’s $80B sales goal by 2030 reflects industry’s penchant for long-term bets

PharmaVoice

Promises made by pharma and biotech companies show confidence in the future of their business and dedication to financial success, R&D and environmental protection.